Clinical Trial Update: Therapeutic Efficacy of "Abroma Agusta" in HbA1c % in NIDDM

View source ↗

Summary

A clinical trial update evaluating the therapeutic efficacy of Abroma Agusta for reducing HbA1c levels in Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Abroma Agusta

Snippet

Sponsor: Fr Muller Homoeopathic Medical College | Conditions: Type II Diabetes Mellitus | Status: AVAILABLE